Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 7—July 2021
Dispatch

Pneumococcal Disease Outbreak at a State Prison, Alabama, USA, September 1–October 10, 20181

Guillermo V. SanchezComments to Author , Constance L. Bourne, Sherri L. Davidson, Mark Ellis, Leora R. Feldstein, Katherine Fay, Nicole E. Brown, Evelyn F. Geeter, Lytasha L. Foster, Charlotte Gilmore, Mary G. McIntyre, Burnestine Taylor, Srinivasan Velusamy, Sopio Chochua, and Almea M. Matanock
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (G.V. Sanchez, L.R. Feldstein, K. Fay, N.E. Brown, S. Velusamy, S. Chochua, A.M. Matanock); Alabama Department of Public Health, Montgomery, Alabama, USA (G.V. Sanchez, C.L. Bourne, S.L. Davidson, M. Ellis, E.F. Geeter, L.L. Foster, C. Gilmore, M.G. McIntyre, B. Taylor)

Main Article

Table 1

Patient demographics, signs, symptoms, and Streptococcus pneumoniae risk factors by case classification in study of pneumococcal disease outbreak at a state prison, Alabama, USA, September 1–October 10, 2018*

Demographics
 Confirmed cases, n = 3
 Probable cases, n = 2
 Suspected cases, n = 35
Median age, y (range)
 46 (44–61)
 42 (26–58)
 39 (23–64)
Race
Black 3 (100) 0 14 (40)
White 0 2 (100) 13 (37)
Unknown
 0
 0
 8 (23)
Signs or symptoms
Fever 2 (67) 1 (50) 15 (43)
Cough 2 (67) 1 (50) 19 (54)
Shortness of breath 1 (33) 2 (100) 4 (11)
Chest pain 1 (33) 1 (50) 6 (17)
Headache 1 (33) 0 11 (31)
Neck stiffness 2 (67) 0 1 (3)
Altered mental status 3 (100) 1 (50) 0
Congestion
 0
 0
 6 (17)
Clinical features and risk factors
Immunocompromising condition† 0 0 3 (9)
Chronic medical condition‡ 1 (33) 1 (50) 6 (17)
Substance use: cigarettes, alcohol, or illicit drugs
 2 (67)
 0
 27 (77)
Assigned housing
Dormitory X 3 (100) 0 11 (31)
Dormitory Y 0 1 (50) 8 (23)
Other dormitories: U, V, W, Z 0 0 16 (46)
Healthcare unit 0
 1 (50)
 0

*Values are no. (%) except as indicated. Table includes composite statistics from both inmate interviews and medical chart abstractions. All identified cases occurred in inmates; no cases were identified among staff members. †Includes immune suppression, chronic renal failure, HIV, solid organ transplant, asplenia, sickle cell disease and other hemoglobinopathies, and malignancy excluding skin cancer (Centers for Disease Control and Prevention Adult Vaccine Schedule, https://www.cdc.gov/vaccines/acip). ‡Includes chronic heart, liver, kidney, lung diseases, and diabetes mellitus; excludes documented substance abuse, Hepatitis C infection, and chronic osteomyelitis (Centers for Disease Control and Prevention Adult Vaccine Schedule, https://www.cdc.gov/vaccines/acip).

Main Article

1Preliminary results from this study were presented at the Centers for Disease Control and Prevention 2019 Epidemic Intelligence Service conference, April 29–May 2, 2019, Atlanta, Georgia, USA.

Page created: April 27, 2021
Page updated: June 17, 2021
Page reviewed: June 17, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external